During the past decade, University of Michigan Cardiovascular Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Michigan Cardiovascular Center" #1 sponsor was "University of Michigan" with 6 trials, followed by "Mespere Lifesciences Inc." with 2 trials sponsored, "Abiomed Inc." with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "Medtronic Cardiac Surgery" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan Cardiovascular Center" #1 collaborator was "University of Michigan" with 2 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "University of Michigan Cardiovascular Center" are "Aortic Stenosis" (1 trials), "Aortic Valve Stenosis" (1 trials), "Atrial Fibrillation" (1 trials), "Cancer" (1 trials) and "Cardiac Arrhythmia" (1 trials). Many other conditions were trialed in "University of Michigan Cardiovascular Center" in a lesser frequency.

Most popular intervention types in "University of Michigan Cardiovascular Center" are "Device" (6 trials), "Behavioral" (2 trials), "Other" (2 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABIOMED, Inc. hemodynamic support devices" (1 trials), "Avoximeter 4000" (1 trials), "Diastolic function assessment" (1 trials), "Echocardiography machine GE Vivid E9" (1 trials) and "Echocardiography system Ultra DCI Model 5000" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Michigan Cardiovascular Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "University of Michigan Cardiovascular Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University of Michigan Cardiovascular Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Michigan Cardiovascular Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".